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SUMMARY. An intervention study of 3 months was performed at a third-level university hospital to inves-
tigate if drug adjustment interventions towards chronic kidney disease (CKD) patients are still needed.
Patients with a glomerular filtration rate < 60 mL/min/1.73 m2 and a prescribed medication that needed
an adjustment for CKD were selected. Demographic and clinical data, prescription information, non-ad-
justed medication, interventions, and acceptance of recommendation were registered. A total of 706 pa-
tients were included (77.5 % stage 3 of CKD, 13.2 % stage 4 and 7.2 % stage 5), 281 (8.5 %) of 3,315 pre-
scriptions were considered non-adjusted (52.3 % stage 3, 28.8 % stage 4 and 18.9 % stage 5) and were in-
tervened: 220 (78.3 %) dose reduction, 32 (11.4 %) contraindicated, 21 (7.5 %) follow up, and 8 (2.8 %)
dose increment. Fifty per cent of the interventions were accepted. Antibiotics became in 45 % of the inter-
ventions. Intervention and education about the important of drug adjustment in CKD is still needed to im-
prove safety on these patients. 
